Literature DB >> 19152365

SHOP: a method for structure-based fragment and scaffold hopping.

Fabien Fontaine1, Simon Cross, Guillem Plasencia, Manuel Pastor, Ismael Zamora.   

Abstract

A new method for fragment and scaffold replacement is presented that generates new families of compounds with biological activity, using GRID molecular interaction fields (MIFs) and the crystal structure of the targets. In contrast to virtual screening strategies, this methodology aims only to replace a fragment of the original molecule, maintaining the other structural elements that are known or suspected to have a critical role in ligand binding. First, we report a validation of the method, recovering up to 95% of the original fragments searched among the top-five proposed solutions, using 164 fragment queries from 11 diverse targets. Second, six key customizable parameters are investigated, concluding that filtering the receptor MIF using the co-crystallized ligand atom type has the greatest impact on the ranking of the proposed solutions. Finally, 11 examples using more realistic scenarios have been performed; diverse chemotypes are returned, including some that are similar to compounds that are known to bind to similar targets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19152365     DOI: 10.1002/cmdc.200800355

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  3 in total

Review 1.  Classification of scaffold-hopping approaches.

Authors:  Hongmao Sun; Gregory Tawa; Anders Wallqvist
Journal:  Drug Discov Today       Date:  2011-10-26       Impact factor: 7.851

2.  Mapping of ligand-binding cavities in proteins.

Authors:  C David Andersson; Brian Y Chen; Anna Linusson
Journal:  Proteins       Date:  2010-05-01

3.  Software-aided approach to investigate peptide structure and metabolic susceptibility of amide bonds in peptide drugs based on high resolution mass spectrometry.

Authors:  Tatiana Radchenko; Andreas Brink; Yves Siegrist; Christopher Kochansky; Alison Bateman; Fabien Fontaine; Luca Morettoni; Ismael Zamora
Journal:  PLoS One       Date:  2017-11-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.